{{Expert-subject|Medicine|date=November 2008}}

{{Infobox disease
 | Name           = Cerebral amyloid angiopathy
 | Image          = Cerebral amyloid angiopathy - very high mag.jpg
 | Caption        = [[Micrograph]] showing cerebral amyloid angiopathy. [[Congo red stain]].
 | DiseasesDB     = 32874
 | ICD10          = {{ICD10|I|68|0|i|68}}
 | ICD9           = 
 | ICDO           = 
 | OMIM           = 
 | MedlinePlus    = 000719
 | eMedicineSubj  = neuro
 | eMedicineTopic = 628
 | MeshID         = D016657
}}
'''Cerebral amyloid angiopathy''' (CAA), also known as '''congophilic angiopathy''',<ref name="pmid16627535">{{cite journal |author=Exley C, Esiri MM |title=Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK |journal=J. Neurol. Neurosurg. Psychiatr. |volume=77 |issue=7 |pages=877–9 |year=2006 |month=July |pmid=16627535 |doi=10.1136/jnnp.2005.086553 |url=http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=16627535 |pmc=2117501}}</ref> is a form of [[angiopathy]] in which [[amyloid]] deposits form in the walls of the blood vessels of the central nervous system.<ref>{{cite journal |author=Revesz T |title=Sporadic and familial cerebral amyloid angiopathies |journal=Brain Pathol. |volume=12 |issue=3 |pages=343–57 |year=2002 |month=July |pmid=12146803 |doi= 10.1111/j.1750-3639.2002.tb00449.x|url= |author-separator=, |author2=Holton JL |author3=Lashley T |display-authors=3 |last4=Plant |first4=Gordon |last5=Rostagno |first5=Agueda |last6=Ghiso |first6=Jorge |last7=Frangione |first7=Blas}}</ref> The term ''congophilic'' is used because the presence of the abnormal aggregations of [[amyloid]] can be demonstrated by microscopic examination of brain [[Biological tissue|tissue]] after application of a special stain called [[Congo red]]. The amyloid material is only found in the brain and as such the disease is not related to other forms of [[amyloidosis]].
==Causes==
CAA has been identified as occurring either sporadically (generally in elderly populations)<ref>{{cite journal |author=Thanvi B and Robinson T. |title=Sporadic cerebral amyloid angiopathy—an important cause of cerebral haemorrhage in older people |journal=Age and Ageing |volume=35 |issue=6 |pages=565–571 |year=2006 |month=September |pmid=16982664 |url=http://ageing.oxfordjournals.org/content/35/6/565.full |doi=10.1093/ageing/afl108}}</ref> or in familial forms such as Flemish, Iowa, and Dutch types.<ref>{{cite journal |author=Hendriks L |title=Presenile demetia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene |journal=Nature Genetics |volume=1 |issue=3 |pages=218–221 |year=1992 |month=June |pmid=1303239  |url=http://publishing.eur.nl/ir/darenet/asset/5803/1091.pdf |doi=10.1038/ng0692-218 |author-separator=, |author2=van Duijn CM |author3=Cras P |display-authors=3 |last4=Cruts |first4=Marc |last5=Van Hul |first5=Wim |last6=Van Harskamp |first6=Frans |last7=Warren |first7=Andrew |last8=McInnis |first8=Melvin G. |last9=Antonarakis |first9=Stylianos E.}}</ref><ref>{{cite journal |author=Grabowski TJ |title=Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy |journal=Annals of Neurology |volume=49 |issue=6 |pages=697–705 |year=2001 |month=June |pmid=11409420 |doi=10.1002/ana.1009 |author-separator=, |author2=Cho HS |author3=Vonsattel JP |display-authors=3 |last4=Rebeck |first4=G. William |last5=Greenberg |first5=Steven M.}}</ref><ref>{{cite journal |title=Hereditary cerebral hemorrhage with amyloidosis-Dutch type |journal=Neuropathology |volume=25 |issue=3 |pages=288–297 |year=2005 |month=December |pmid=16382777 |doi=10.1111/j.1440-1789.2005.00631.x |author=Maat-Schieman M, Roos R, van Duinen S.}}</ref>  Sporadic forms of CAA have been further characterized into two types based on deposition of [[beta amyloid|amyloid β-protein]] (Aβ) in cortical capillaries.<ref>{{cite journal |authors=Thal DR |title=Two Types of Sporadic Cerebral Amyloid Angiopathy |journal=Journal of Neuropathology & Experimental Neurology |volume=61 |issue=3 |pages=282–293 |year=2002 |month=March |pmid=11895043  |url=http://journals.lww.com/jneuropath/pages/articleviewer.aspx?year=2002&issue=03000&article=00011&type=abstract |author=Thal DR, Ghebremedhin E, R&uuml;b U, Yamaguchi H, Del Tredici K, Braak H |author-separator=, |display-authors=3}}</ref>  In all cases, it is defined by the deposition of Aβ in the [[Leptomeninges|leptomeningal]] and [[Cerebrum|cerebral]] vessel walls.<ref>{{cite journal |author=Glenner GG, Henry JH, Fujihara S. |title=Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration |journal=Annales de Pathologie |volume=1 |issue=2 |pages=120–129 |year=1981 |pmid=6169353}}</ref>

The reason for increased deposition of Aβ in sporadic CAA is still unclear with both increased production of the peptide<ref>{{cite journal |title=Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients |journal=Proceedings of the National Academy of Sciences of the United States of America |volume=101 |issue=1 |pages=3632–3637 |year=2004 |month=March |pmid=14978286 |doi=10.1073/pnas.0205689101 |pmc=373514 |author-separator=, |author2=Lindholm K |author3=Yang LB |display-authors=3 |author=Li R |last4=Yue |first4=X |last5=Citron |first5=M |last6=Yan |first6=R |last7=Beach |first7=T |last8=Sue |first8=L |last9=Sabbagh |first9=M}}</ref> and abnormal clearance having been proposed as potential causes.<ref name="nature.com">{{cite journal |title=Identification of the major Abeta1–42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition |journal=Nature Medicine |volume=6 |issue=2 |pages=143–150 |year=2000 |month=February |pmid=10655101 |url=http://www.nature.com/nm/journal/v6/n2/full/nm0200_143.html |doi=10.1038/72237 |author-separator=, |author2=Tsubuki S |author3=Takaki Y |display-authors=3 |author=Iwata N |last4=Takaki |first4=Yoshie |last5=Watanabe |first5=Kaori |last6=Sekiguchi |first6=Misaki |last7=Hosoki |first7=Emi |last8=Kawashima-Morishima |first8=Maho |last9=Lee |first9=Hahn-Jun}}</ref><ref name="Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE 1998 725–733">{{cite journal |authors=Weller RO |title=Cerebral Amyloid Angiopathy : Amyloid β Accumulates in Putative Interstitial Fluid Drainage Pathways in Alzheimer's Disease |journal= American Journal of Pathology |volume=153 |issue=3 |pages=725–733 |year=1998 |month=September |pmid=9736023 |url=http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6PJN-51TH968-B&_user=489277&_coverDate=09%2F30%2F1998&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_acct=C000022679&_version=1&_urlVersion=0&_userid=489277&md5=1b956d613f8056b1286445138d81f353&searchtype=a |pmc=1853019 |author=Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE |author-separator=, |display-authors=3 |doi=10.1016/S0002-9440(10)65616-7}}</ref>  Under normal physiology Aβ is cleared from the brain by four pathways: (1) [[endocytosis]] by [[astrocyte]]s and [[microglia]]l cells,<ref>{{cite journal |title=Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse |journal=Nature |volume=400 |issue=6740 |pages=173–177 |year=1999 |month=July |pmid=10408445 |url=http://www.nature.com/nature/journal/v400/n6740/full/400173a0.html |doi=10.1038/22124 |author-separator=, |author2=Barbour R |author3=Dunn W |display-authors=3 |author=Schenk D |last4=Gordon |first4=Grace |last5=Grajeda |first5=Henry |last6=Guido |first6=Teresa |last7=Hu |first7=Kang |last8=Huang |first8=Jiping |last9=Johnson-Wood |first9=Kelly}}</ref> (2) enzymatic degradation by [[neprilysin]] or [[Insulin degrading enzyme|insulysin]]<ref name="nature.com"/> (3) cleared by way of the [[Blood-brain barrier|blood brain barrier]]<ref>{{cite journal |title=Neurovascular mechanisms of Alzheimer's neurodegeneration |journal=Trends in Neurosciences |volume=28 |issue=4 |pages=202–208 |year=2005 |month=April |pmid=15808355 |url=http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T0V-4FGX80H-1&_user=489277&_coverDate=04%2F30%2F2005&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_acct=C000022679&_version=1&_urlVersion=0&_userid=489277&md5=02da7812480bc9f4b1dc0926715190e6&searchtype=a |doi=10.1016/j.tins.2005.02.001 |author=Zlokovic BV}}</ref> or (4) drained along periarterial spaces.<ref name="Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE 1998 725–733"/>  Abnormalities in each of these identified clearance pathways have been linked to CAA.

In familial forms of CAA, the cause of Aβ build up is likely due to increased production rather than poor clearance.<ref>{{cite journal |title=Cerebral Amyloid Angiopathy and its relationship to Alzheimer's disease |journal=Acta Neuropathologica |volume=115 |issue=6 |pages=599–609 |year=2008 |month=June |pmid=18369648 |url=http://www.springerlink.com/content/0211106350176618/fulltext.pdf |doi=10.1007/s00401-008-0366-2 |author=Thal DR, Griffin WS, de Vos RA, Ghebremedhin E.}}</ref>  Mutations in the [[amyloid precursor protein]] (APP), [[Presenilin]] (PS) 1 and PS2 genes can result in increased rates of cleavage of the APP into Aβ.<ref>{{cite journal |title=The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics |journal=Science |volume=297 |issue=5580 |pages=353–356 |year=2002 |month=September |pmid=12130773 |url=http://www.sciencemag.org/content/297/5580/353.long |doi=10.1126/science.1072994 |author=Hardy J and Selkoe DJ}}</ref>

An immune mechanism has also been proposed.<ref>{{cite journal |author=Yamada M |title=Immune reactions associated with cerebral amyloid angiopathy |journal=Stroke |volume=27 |issue=7 |pages=1155–62 |year=1996 |month=July |pmid=8685920 |doi= 10.1161/01.STR.27.7.1155|url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=8685920 |author-separator=, |author2=Itoh Y |author3=Shintaku M |display-authors=3 |last4=Kawamura |first4=J |last5=Jensson |first5=O |last6=Thorsteinsson |first6=L |last7=Suematsu |first7=N |last8=Matsushita |first8=M |last9=Otomo |first9=E}}</ref>

==Presentation==
Amyloid deposition predisposes these blood vessels to failure, increasing the risk of a [[hemorrhagic stroke]].  Since this can be caused by the same amyloid protein that is associated with Alzheimer's dementia<ref name="pmid18369648">{{cite journal |author=Thal DR, Griffin WS, de Vos RA, Ghebremedhin E |title=Cerebral amyloid angiopathy and its relationship to Alzheimer's disease |journal=Acta Neuropathol. |volume=115 |issue=6 |pages=599–609 |year=2008 |month=June |pmid=18369648 |doi=10.1007/s00401-008-0366-2}}</ref> such brain hemorrhages are more common in people who suffer from Alzheimer's, however they can also occur in those who have no history of [[dementia]].  The hemorrhage within the brain is usually confined to a particular lobe and this is slightly different compared to brain hemorrhages which occur as a consequence of high blood pressure ([[hypertension]]) - a more common cause of a hemorrhagic stroke (or [[cerebral hemorrhage]]).

==Diagnosis==
[[File:Compare SWI and GRE CAA.png|thumb|450px|MRI showing low signal foci in cerebral amyloid angiopathy. Conventional gradient echo T2*-weighted image (left, TE=20ms), susceptibility weighted image (SWI) and SWI phase image (center and right, respectively, TE=40ms) at 1.5 Tesla.]]
[[File:Amyloidangiopathie Kongorot.jpg|thumb|[[Histopathology]] of cerebral amyloid angiopathy. Deposition of [[amyloid]] (red) in [[hyaline|hyalinized]] vessel walls on [[congo red]] staining.]][[File:Amyloidangiopathie Kongorot doppelbrechend.jpg|thumb|[[Birefringence]] in [[polarized light]] of amyloid material in blood vessel walls.]]
[[Susceptibility weighted imaging]] has been proposed as a tool for identifying CAA-related microhemorrhages.<ref name="pmid17297004">{{cite journal |author=Haacke EM |title=Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging |journal=AJNR Am J Neuroradiol |volume=28 |issue=2 |pages=316–7 |year=2007 |month=February |pmid=17297004 |doi= |url=http://www.ajnr.org/cgi/pmidlookup?view=long&pmid=17297004 |author-separator=, |author2=DelProposto ZS |author3=Chaturvedi S |display-authors=3 |last4=Sehgal |first4=V |last5=Tenzer |first5=M |last6=Neelavalli |first6=J |last7=Kido |first7=D}}</ref>

[[Biopsy|Biopsies]] also play a role in diagnosing the condition.<ref>{{cite journal |author=Greenberg SM, Vonsattel JP |title=Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy |journal=Stroke |volume=28 |issue=7 |pages=1418–22 |year=1997 |month=July |pmid=9227694 |doi= 10.1161/01.STR.28.7.1418|url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=9227694}}</ref>

==Types==
It is usually associated with [[amyloid beta]].<ref name="pmid16973779">{{cite journal |author=Chao CP, Kotsenas AL, Broderick DF |title=Cerebral amyloid angiopathy: CT and MR imaging findings |journal=Radiographics |volume=26 |issue=5 |pages=1517–31 |year=2006 |pmid=16973779 |doi=10.1148/rg.265055090 |url=http://radiographics.rsnajnls.org/cgi/pmidlookup?view=long&pmid=16973779}}</ref> This form has been associated with "Abeta-related [[angiitis]]".<ref>{{cite journal |author=Scolding NJ |title=Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy |journal=Brain |volume=128 |issue=Pt 3 |pages=500–15 |year=2005 |month=March |pmid=15659428 |doi=10.1093/brain/awh379 |url=http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15659428 |author-separator=, |author2=Joseph F |author3=Kirby PA |display-authors=3 |last4=Mazanti |first4=I |last5=Gray |first5=F |last6=Mikol |first6=J |last7=Ellison |first7=D |last8=Hilton |first8=DA |last9=Williams |first9=TL}}</ref>

However, there are other types:

* the "Icelandic type" is associated with [[Cystatin C]].<ref name="pmid18508448">{{cite journal |author=Nagai A |title=Involvement of cystatin C in pathophysiology of CNS diseases |journal=Front. Biosci. |volume=13 |issue= 13|pages=3470–9 |year=2008 |pmid=18508448 |doi= 10.2741/2941|url=http://www.bioscience.org/2008/v13/af/2941/fulltext.htm |author-separator=, |author2=Terashima M |author3=Sheikh AM |display-authors=3 |last4=Notsu |first4=Y |last5=Shimode |first5=K |last6=Yamaguchi |first6=S |last7=Kobayashi |first7=S |last8=Kim |first8=SU |last9=Masuda |first9=J}}</ref>
* the "British type" is associated with [[ITM2B]] (also known as "BRI").<ref name="pmid10391242">{{cite journal |author=Vidal R |title=A stop-codon mutation in the BRI gene associated with familial British dementia |journal=Nature |volume=399 |issue=6738 |pages=776–81 |year=1999 |month=June |pmid=10391242 |doi=10.1038/21637 |author-separator=, |author2=Frangione B |author3=Rostagno A |display-authors=3 |last4=Rostagno |first4=Agueda |last5=Mead |first5=Simon |last6=Révész |first6=Tamas |last7=Plant |first7=Gordon}}</ref>

Research is currently being conducted to determine if there is a link between cerebral amyloid angiopathy and ingestion of excessive quantities of aluminium, as occurred in the [[Camelford water pollution incident]].<ref>{{cite news| url=http://www.dailymail.co.uk/news/article-1052696/Coroner-slams-Government-refusing-fund-probe-deaths-worst-water-poisoning-cases-British-history.html | location=London | work=Daily Mail | title=Government slammed for refusing to fund probe into death after one of worst water poisoning cases in British history | date=5 September 2008}}</ref>

==References==
{{Reflist|2}}

==External links==
* [http://www.angiopathy.org/ Cerebral Amyloid Angiopathy research group at the Massachusetts General Hospital in Boston]

{{Amyloidosis}}

[[Category:Vascular diseases]]
[[Category:Brain disorders]]